Nukkleus (NUKK) director awarded 5,000 shares under equity plan
Nukkleus Inc. (NUKK) reported a director equity award on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nukkleus Inc. (NUKK) reported a director equity award on a Form 4. On 11/13/2025, the reporting person, serving as a director, acquired 5,000 shares of common stock at a price of $0. The filing explains that these shares were issued under the company's 2025 Equity Incentive Plan in consideration for services provided to the company. Following this transaction, the reporting person beneficially owned 15,000 shares of Nukkleus common stock, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.0001 par value per share | 5,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares were issued to the reporting person under the Company's 2025 Equity Incentive Plan in consideration of services rendered to the Company.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Nukkleus Inc. (NUKK) report on this Form 4?
Nukkleus Inc. reported that a director acquired 5,000 shares of its common stock on 11/13/2025 in a transaction recorded on Form 4.
What is the reporting person's relationship to Nukkleus Inc. (NUKK)?
The reporting person is identified as a director of Nukkleus Inc., as indicated in the relationship section of the Form 4.
Is this NUKK Form 4 filed by one or multiple reporting persons?
The Form 4 is indicated as being filed by one reporting person, not a group filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.